Marla Anderson, MD, discusses what questions breast cancer patients have before surgery and about the recovery.

Cabozantinib, an oral tyrosine kinase inhibitor, has been approved by the U.S. Food and Drug Administration (FDA) for the treatment of patients with previously treated advanced neuroendocrine tumors ...

Exelixis, Inc. (Nasdaq: EXEL) today announced that the U.S. Food and Drug Administration (FDA) has approved CABOMETYX® (cabozantinib) for the treatment of 1) adult and pediatric patients 12 years of ...

The FDA approval was based on results from the CABINET study, a phase 3 pivotal trial evaluating cabozantinib compared with ...

“Our study shows that ultra-rapid droplet digital PCR could be a fast and efficient tool for making a molecular diagnosis during surgery for brain cancer,” co-senior author Gilad D. Evrony, M.D., Ph.D ...

"It would be revolutionary, to be honest, because right now, all breast cancer patients are recommended to undergo surgery, ...

Dublin, March 14, 2025 (GLOBE NEWSWIRE) -- The "Carcinoid Tumor Market" report has been added to ResearchAndMarkets.com's offering. The global demand for advanced carcinoid tumor treatments is ...

Teddi Mellencamp is in the fight of her life. After undergoing surgery last month to remove brain tumors, the former “Real Housewives of Beverly Hills” star, 43, revealed more cancer has ...

Teddi Mellencamp’s doctors discovered more tumors in her body after she underwent emergency brain surgery last month. The "Real Housewives of Beverly Hills" star shared a health update on her ...

Teddi Mellencamp revealed that more tumors have been found in her brain and lungs. On Thursday, March 6, the Real Housewives of Beverly Hills alum, 43, posted a health update to her Instagram ...